Abstract
Blood selenium has been shown to decline as breast cancer progresses and fluctuate with estrogen. The objective of this study was to determine the effect of estrogen depletion resulting from chemotherapy-induced ovarian failure on serum selenium and selenoproteins in stage I/II premenopausal breast cancer patients. Serum selenium, glutathione peroxidase (GPx) activity, and selenoprotein P (SelP) were measured and a dietary questionnaire was completed at baseline (before chemotherapy) and 6, 12, and 24 months after start of chemotherapy. Twelve months after the start of adjuvant chemotherapy 33 (75%) patients developed ovarian failure (OF) and 11 (25%) retained menstrual function (non-OF). Dietary selenium intake was 30–58% above the Recommended Dietary Allowance for both groups. By six months the mean estradiol (pg/ml) was lower in the OF group than in the non-OF group (32±5 versus 140±62 pg/ml, p=0.01) and this difference was maintained at 12 and 24 months. However, there was no differences in serum selenium, GPx activity, or SelP in the OF and non-OF groups at 6, 12, and 24 months. Selenium status in premenopausal breast cancer patients, as measured by serum selenium, GPx and SelP, was within the normal range before and following adjuvant chemotherapy, and was not affected by chemotherapy-induced ovarian failure.
Similar content being viewed by others
References
El-Bayoumy K, Chae YH, Upadhyaya P, Meschter C, Cohen LA, Reddy BS, Inhibition of 7,12-dimethylbenz(a)anthracene-induced tumors and DNA adduct formation in the mammary glands of female Sprague-Dawley rats by the synthetic organoselenium compound, 1,4-phenylenebis(methylene)selenocyanate Cancer Res 52:2402-2407 1992
Ip C, Lisk DJ, Ganther HE, Chemoprevention with triphenylselenonium chloride in selenium-deficient rats Anticancer Res 20:4179–4182 2000
Cornstock GW, Bush TL, Helzlsouer K, Serum retinol, beta carotene, vitamin E, and selenium as related to subsequent cancer of specific sites Am J Epidemiol 135:115–121 1992
Willett WC, Polk BF, Morris JS, Stampfer MJ, Pressel S, Rosner B, Taylor JO, Schneider K, Hames CG, Prediagnostic serum selenium and risk of cancer Lancet 2:130–134 1983
Salonen JT, Alfthan G, Huttunen JK, Puska P, Association between serum selenium and the risk of cancer Am J Epidemiol 120:342–349 1984
Ujiie S, Kikuchi H, The relation between serum selenium value and cancer in Miyagi, Japan: 5-year follow up study Tohoku J Exp Med 196:99–109 2002
Kumar K, Thangaraju M, Sachdanandam P, Changes observed in antioxidant system in the blood of post-menopausal women with breast cancer Bioch Intl 25:371–380 1991
Hardell L, Danell M, Angqvist CA, Marklund SL, Fredriksson M, Zakari AL, Kjellgren A, Levels of selenium in plasma and glutathione peroxidase in erythrocytes and the risk of breast cancer Biol Tr Ele Res 36:99–108 1993
Huang Y, Sheu J, Lin T, Association between oxidative stress and changes of trace elements in patients with breast cancer Clin Biochem 32:131–136 1999
McConnell KP, Jager RM, Bland KI, Blotcky AJ, The relationship of dietary selenium and breast cancer J Surg Oncol 15:67–70 1980
Chaitchik S, Shenberg C, Nir-El Y, Mantel M, The distribution of selenium in human blood samples of Israeli population–comparison between normal and breast cancer cases Biol Trace Elem Res 15:205–212 1988
Lopez-Saez JB, Senra-Varela A, Pousa-Estevez L, Selenium in breast cancer Oncology 64:227–231 2003
van’t Veer P, van der Wielen RP, Kok FJ, Hermus RJ, Sturmans F, Selenium in the diet, blood, and toenails in relation to breast cancer: a case-control study Am J Epidemiol 131:987–994 1990
Ghadirian P, Maisonneuve P, Perret C, Kennedy G, Boyle P, Krewski D, Lacroix A, A case-control study of toenail selenium and cancer of the breast, colon, and prostate Cancer Detect Prev 24:305–313 2000
Mannisto S, Alfthan G, Virtanen M, Kataja V, Uusitupa M, Pietinen P, Toenail selenium and breast cancer-a case-control study in Finland Eur J Clin Nutr 54:98–103 2000
Dorgan JF, Sowell A, Swanson CA, Potischman N, Miller R, Schussler N, Stephenson HE Jr, Relationships of serum carotenoids, retinol, alpha-tocopherol, and selenium with breast cancer risk: results from a prospective study in Columbia, Missouri (United States) Cancer Causes Control 9:89–97 1998
Smith AM, Cha C, Kimura RE, Plasma selenium and glutathione peroxidase activity fluctuate during the rat estrous cycle Nutr Res 15:267–277 1995
Ha EJ, Smith AM, Plasma selenium and plasma and erythrocyte glutathione peroxidase activity increase with estrogen during the menstrual cycle J Am Coll Nutr 22:43–51 2003
Smith AM, Chang MP-H, Medeiros LC, Generational differences in selenium status of women Biol Tr Ele Res 75:157–165 2000
Shapiro CL, Recht A, Side effects of adjuvant treatment of breast cancer N Engl J Med 344:1997–2008 2001
Shapiro CL, Manola J, Lebuff M, Ovarian failure after adjuvant chemotherapy is associated with rapid bone loss in women with early-stage breast cancer J Clin Oncol 19:3306–3311 2001
McCarthy TP, Brodie B, Milner JA, Bevill RF, Improved method for selenium determination in biological sample by gas chromatography J Chromat 225:9–16 1981
Paglia DE, Valentine WN, Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase J Lab Clin Med 70:158–169, 1967
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ, 1951 Protein measurement with the Folin phenol reagent J Biol Chem 193:265 1967
Hill KE, Xia Y, Akesson B, Boeglin ME, Burk RF, Selenoprotein P concentration in plasma is an index of selenium status in selenium-deficient and selenium-supplemented Chinese subjects J Nutr 126:138–145 1996
Akesson B, Bellew T, Burk RF, Purification of selenoprotein P from human plasma Biochim Biophys Acta 1204:243–249 1994
Avissar N, Whitin JC, Allen PZ, Palmer IS, Cohen HJ, Antihuman plasma glutathione peroxidase antibodies: immunologic investigations to determine plasma glutathione peroxidase protein and selenium content in plasma Blood 73:318–323 1989
Block G, Hartman AM, Dresser CM, Carroll MD, Gannon J, Gardner L, A data-based approach to diet questionnaire design and testing Am J Epidemiol 124:453–469 1986
Block B, Woods M, Potosky A, Clifford C, Validation of a self- administered diet history questionnaire using multiple diet records J Clin Epidemiol 43:1327–1335 1990
Newman V, Rock CL, Faerber S, Flatt S, Wright AA, Pierce JP, Dietary supplement use by women at risk for breast cancer recurrence J Am Diet Assoc 98:285–292 1998
Vernie LN, De Vries M, Benckhuijsen C, De Goeij JJ, Zegers C, Selenium levels in blood and plasma, and glutathione peroxidase activity in blood of breast cancer patients during adjuvant treatment with cyclophosphamide, methotrexate and 5-fluorouracil Cancer Lett 18:283–289 1983
Pleban PA, Munyani A, Beachum J, Determination of selenium concentration and glutathione peroxidase activity in plasma and erythrocytes Clin Chem 28:311–316 1982
Levander OA, Moser PB, Morris VC, Dietary selenium intake and selenium concentrations of plasma, erythrocytes, and breast milk in pregnant and postpartum lactating and nonlactating women Am J Clin Nutr 46:694–698 1987
Institute of Medicine, 2000 Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, Carotenoids. National Academy Press, Washington DC, 284–342
Alfthan G, Neve J, Reference values for serum selenium in various areas-evaluated according to the TRACY protocol J Trace Elem Med Biol 10:77–87 1996
Bernstein BJ, Grasso T, Prevalence of complementary and alternative medicine use in cancer patients Oncology 15:1267–1272 2001
Burk RF, Hill KE, Motley AK, Plasma selenium in specific and non-specific forms Biofactors 14:107–114 2001
Burk RF, Early DS, Hill KE, Palmer IS, Boeglin ME, Plasma selenium in patient with cirrhosis Hepatology 27:794–798 1998
Gao Y, Wang Z, Separation and detection of selenium-containing proteins in human serum Fresenius J Anal Chem 367:60–64 2000
Deagen JT, Butler JA, Zachara BA, Whanger PD, Determination of the distribution of selenium between glutathione peroxidase, selenoprotein P, and albumin in plasma Anal Biochem 208:176–181 1993
Saito Y, Takahashi K, Characterization of selenoprotein P as a selenium supply protein Eur J Biochem 269:5746–5751 2002
Acknowledgements
The authors are grateful to Xiaodong Zhou for analysis of glutathione peroxidase activity. This study was funded by an Ohio Agricultural Research and Development Center Competitive Grant (Smith), NIH grant ES002497 (Burk), and NCI grant R29 CA60050-06 (Shapiro).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Breedlove, H.A., Smith, A.M., Burk, R.F. et al. Serum selenium measurements in women with early-stage breast cancer with and without chemotherapy-induced ovarian failure. Breast Cancer Res Treat 97, 225–230 (2006). https://doi.org/10.1007/s10549-005-9012-z
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10549-005-9012-z